Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Sarcoma 1Gynecologic 1CNS 1

Conditions

Carcinoma, Merkel Cell 2Uveal Melanoma 1Melanoma 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 194aldesleukin 145Interleukin-2 109fludarabine phosphate 107Temozolomide 83fludarabine 81Dacarbazine 81Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Magnetic Resonance Spectroscopy 48Carboplatin 48Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42Specimen Handling 42atezolizumab 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Interferon-beta × Dermatologic × Clear all
NCT02584829 2022-03-22

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
8 enrolled 16 charts
Dermatologic

Carcinoma, Merkel Cell

NCT01758458 2017-04-19

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
4 enrolled
Dermatologic

Carcinoma, Merkel Cell

NCT00085306 2015-10-02

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Case Comprehensive Cancer Center

Phase 2 Completed
21 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡